A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

被引:13
|
作者
Thijssen, Vito [1 ,2 ]
Hurdiss, Daniel L. [3 ]
Debski-Antoniak, Oliver J. [3 ]
Spence, Matthew A. [4 ]
Franck, Charlotte [5 ,6 ]
Norman, Alexander [5 ,6 ]
Aggarwal, Anupriya [7 ]
Mokiem, Nadia J. [8 ,9 ]
van Dongen, David A. A. [1 ,8 ,9 ]
Vermeir, Stein W. [1 ,2 ]
Liu, Minglong [1 ,2 ]
Li, Wentao [3 ]
Chatziandreou, Marianthi [3 ]
Donselaar, Tim [3 ]
Du, Wenjuan [3 ]
Drulyte, Ieva [10 ]
Bosch, Berend-Jan [3 ]
Snijder, Joost [8 ,9 ]
Turville, Stuart G. [7 ]
Payne, Richard J. [5 ,6 ]
Jackson, Colin J. [4 ,11 ,12 ]
van Kuppeveld, Frank J. M. [3 ]
Jongkees, Seino A. K. [1 ,2 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Chem Biol & Drug Discovery, NL-3584 CG Utrecht, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands
[3] Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Sect Virol,Div Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands
[4] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia
[5] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[6] Univ Sydney, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Sydney, NSW 2006, Australia
[7] Kirby Inst, Sydney, NSW 2052, Australia
[8] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands
[9] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands
[10] Thermo Fisher Sci, Mat & Struct Anal, NL-5651 GG Eindhoven, Netherlands
[11] Australian Natl Univ, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Canberra, ACT 2601, Australia
[12] Australian Natl Univ, Australian Res Council, Ctr Excellence Synthet Biol, Canberra, ACT 2601, Australia
基金
澳大利亚研究理事会; 荷兰研究理事会; 比尔及梅琳达.盖茨基金会;
关键词
macrocyclic peptides; mRNA display; SARS-CoV-2; antivirals; Cryo-EM; DISCOVERY; APTAMERS; DOMAIN;
D O I
10.1073/pnas.2303292120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ongoing COVID-19 pandemic has had great societal and health consequences. Despite the availability of vaccines, infection rates remain high due to immune evasive Omicron sublineages. Broad-spectrum antivirals are needed to safeguard against emerging variants and future pandemics. We used messenger RNA (mRNA) display under a reprogrammed genetic code to find a spike-targeting macrocyclic peptide that inhibits SARS-CoV- 2 (severe acute respiratory syndrome coronavirus 2) Wuhan strain infection and pseudoviruses containing spike proteins of SARS-CoV- 2 variants or related sarbecoviruses. Structural and bioinformatic analyses reveal a conserved binding pocket between the receptor-binding domain, N-terminal domain, and S2 region, distal to the angiotensin-converting enzyme 2 receptor-interaction site. Our data reveal a hitherto unexplored site of vulnerability in sarbecoviruses that peptides and potentially other drug-like molecules can target.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo
    Narayan, Rohan
    Sharma, Mansi
    Yadav, Rajesh
    Biji, Abhijith
    Khatun, Oyahida
    Kaur, Sumandeep
    Kanojia, Aditi
    Joy, Christy Margrat
    Rajmani, Raju
    Sharma, Pallavi Raj
    Jeyasankar, Sharumathi
    Rani, Priya
    Shandil, Radha Krishan
    Narayanan, Shridhar
    Rao, Durga Chilakalapudi
    Satchidanandam, Vijaya
    Das, Saumitra
    Agarwal, Rachit
    Tripathi, Shashank
    CELL REPORTS MEDICINE, 2023, 4 (08)
  • [22] Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders
    Chuang, Sung-Ting
    Buchwald, Peter
    PHARMACEUTICALS, 2022, 15 (09)
  • [23] HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration
    Lu, Ying
    Shen, Fan
    He, Wen-Qiang
    Li, An-Qi
    Li, Ming-Hua
    Feng, Xiao-Li
    Zheng, Yong-Tang
    Pang, Wei
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (08) : 3339 - 3351
  • [24] HR121 targeting HR2 domain in S2 subunit of spike protein can serve as a broad-spectrum SARS-CoV-2 inhibitor via intranasal administration
    Ying Lu
    Fan Shen
    Wen-Qiang He
    An-Qi Li
    Ming-Hua Li
    Xiao-Li Feng
    Yong-Tang Zheng
    Wei Pang
    Acta Pharmaceutica Sinica B, 2023, (08) : 3339 - 3351
  • [25] Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
    Chen, Yuliu
    Wu, Yan
    Chen, Shaoying
    Zhan, Qingping
    Wu, Dingzhou
    Yang, Chan
    He, Xiaoxue
    Qiu, Mengjie
    Zhang, Nannan
    Li, Zhaofeng
    Guo, Yunhua
    Wen, Minjun
    Lu, Lu
    Ma, Cuiqing
    Guo, Jiayin
    Xu, Wei
    Li, Xiaojuan
    Li, Lin
    Jiang, Shibo
    Pan, Xiaoyan
    Liu, Shuwen
    Tan, Suiyi
    JOURNAL OF VIROLOGY, 2022, 96 (24)
  • [26] The spectrum of SARS-CoV-2 associated polyradiculitis is broad
    Fiorini, A. C.
    Finsterer, J.
    Scorza, F. A.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2021, 114 (11) : 835 - 835
  • [27] The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2
    Vicente, Josefina
    Benedetti, Martina
    Martelliti, Paula
    Vazquez, Luciana
    Gentilini, Maria Virginia
    Penaranda Figueredo, Freddy Armando
    Nabaes Jodar, Mercedes Soledad
    Viegas, Mariana
    Barquero, Andrea Alejandra
    Bueno, Carlos Alberto
    VIRUSES-BASEL, 2023, 15 (04):
  • [28] Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants
    He, Lei
    Wu, Qian
    Zhang, Zhaoyong
    Chen, Lingling
    Yu, Kuai
    Li, Leibin
    Jia, Qiong
    Wang, Yanqun
    Ni, Jianqiang
    Wang, Chuanbin
    Li, Qi
    Zhai, Xinyan
    Zhao, Jincun
    Liu, Yuliang
    Fan, Ruiwen
    Li, Yi-Ping
    MOLECULAR PHARMACEUTICS, 2024, 21 (08) : 3866 - 3879
  • [29] Core fucose-specific Pholiota squarrosa lectin (PhoSL) as a potent broad-spectrum inhibitor of SARS-CoV-2 infection
    Yamasaki, Kazuhiko
    Adachi, Naruhiko
    Tun, Mya Myat Ngwe
    Ikeda, Akihito
    Moriya, Toshio
    Kawasaki, Masato
    Yamasaki, Tomoko
    Kubota, Tomomi
    Nagashima, Izuru
    Shimizu, Hiroki
    Tateno, Hiroaki
    Morita, Kouichi
    FEBS JOURNAL, 2023, 290 (02) : 412 - 427
  • [30] Cellular signalling by SARS-CoV-2 spike protein
    Gracie, Nicholas P.
    Lai, Lachlan Y. S.
    Newsome, Timothy P.
    MICROBIOLOGY AUSTRALIA, 2024, 45 (01) : 13 - 17